ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC50251-50mg |
|
1962925-29-6 |
PF 3084014 hydrobromide
|
0 | — | |
GC50251-10mg |
|
1962925-29-6 |
PF 3084014 hydrobromide
|
0 | — | |
GC50250-50mg |
|
1704741-11-6 |
AZ PFKFB3 67
|
0 | — | |
GC50250-10mg |
|
1704741-11-6 |
AZ PFKFB3 67
|
0 | — | |
GC50249-50mg |
|
21373-30-8 |
6-Hydroxy-DL-DOPA
|
0 | — | |
GC50249-10mg |
|
21373-30-8 |
6-Hydroxy-DL-DOPA
|
0 | — | |
GC50248-50mg |
|
1646499-97-9 |
ML 382
|
0 | — | |
GC50248-10mg |
|
1646499-97-9 |
ML 382
|
0 | — | |
GC50247-10mg |
|
195704-72-4 |
A 127722
|
0 | — | |
GC50246-50mg |
|
1642187-96-9 |
TASP 0390325
|
0 | — | |
GC50246-10mg |
|
1642187-96-9 |
TASP 0390325
|
0 | — | |
GC50245-50mg |
|
— |
(+/-)-ADX 71743
|
0 | — | |
GC50245-10mg |
|
— |
(+/-)-ADX 71743
|
0 | — | |
GC50244-10mg |
|
912921-26-7 |
4-ethynyl-N-ethyl-1,8-naphthalimide
|
0 | — | |
GC50243-1mg |
|
592517-80-1 |
NFAT inhibitor, Cell Permeable
|
0 | — | |
GC50242-50mg |
|
1832713-02-6 |
RA 839
|
0 | — | |
GC50242-10mg |
|
1832713-02-6 |
RA 839
|
0 | — | |
GC50241-50mg |
|
613263-00-6 |
M62812
|
0 | — | |
GC50241-10mg |
|
613263-00-6 |
M62812
|
0 | — | |
GC50240-10mg |
|
1169483-24-2 |
AMG 853
|
0 | — | |